slides · global inventory
Traction
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,471
Current window 5,731-5,760
Pages 350
Rows per page 30
Slide type
5,731-5,760 of 10,471
43
The slide presents two charts: a tumor volume growth curve over time and a PK/PD profile showing drug concentration and target knockdown over 240 hours.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
47
Includes a line chart showing % change over time and a summary table of patient-level degradation data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
48
Includes bar charts for SAA/CRP, a longitudinal line chart for SOCS3, and a scatter plot showing correlation.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
49
Data cut-off date May 1, 2023. DL1-3 completed, DL4 open.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
54
Data presented as tumor volume growth curves and Kaplan-Meier survival plots.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
56
Shows two distinct experiments: DFAM-68555 (leukemia burden) and MOLM-13 (tumor volume).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
11
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue mix shift.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations 1 hit
20
The slide uses stacked bar charts to break down GCR and ODR segments for Revenue and Gross Profit, and simple bars for Adjusted EBITDA.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
21
The slide uses stacked bar charts to show segment contribution (GCR vs ODR) and simple bar charts for EBITDA.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue mix shift.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
21
The slide uses stacked bar charts to break down performance by GCR and ODR segments.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
22
The slide uses stacked bar charts to show segment contributions (GCR vs ODR) and simple bar charts for EBITDA.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
14
The slide provides a breakdown of vehicle orders (buses vs trucks) and charging station orders, alongside logos of school bus and truck clients.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations 1 hit
15
Lion Electric | Investor Presentation Deck | 32 slidesLion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations 1 hit
16
Includes specific details on truck volume, manufacturing capacity, ownership stake, and vesting conditions.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Includes details on senior credit facility extension and ATM program cancellation.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
The chart highlights specific economic periods (Recessionary and COVID Pandemic) and shows long-term growth trends.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
17
The chart highlights specific economic periods (Recessionary and COVID) to demonstrate dividend resilience.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The chart uses a stacked bar approach to distinguish between monthly and supplemental dividends, with annotations for recessionary and COVID periods.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
23
LMM stands for Lower Middle Market.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
34
The slide shows two bar charts side-by-side. The final bars are highlighted in green, likely indicating a partial period or a specific status.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
35
The chart uses a combination of a bar chart for portfolio investments and a line chart for DNII per share.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
46
The chart highlights specific market periods including a recessionary period and the COVID pandemic period.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
10
Slide uses a 3-column layout to categorize achievements by strategic pillar.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Includes a citation of a study from the Université de Sherbrooke published in 'cancers'.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations Loop · Golden Circle1 hit
08
The slide highlights business development traction through licensing agreements.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
09
Matinas BioPharma | Investor Presentation Deck | 28 slidesMatinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
11
The slide uses a timeline-like visualization for each patient to show the rapid decline of fungal load over a short period (12-14 days).Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
22
The slide compares Matinas' PS-NP technology stability (17 weeks) against Moderna (30 days) and Pfizer/BioNTech (10 weeks) at refrigerated temperatures.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
23
The slide shows quantitative radiance data (p/s/cm²/sr) comparing control groups to PS-NP LUC mRNA groups at various time points.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit